You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 43 No. 2, February 1986 TABLE OF CONTENTS
  Archives
  •  Online Features
  ORIGINAL CONTRIBUTIONS
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal

The Effect of Dexamethasone on L-{alpha}-Lysophosphatidyl Choline (Lysolecithin)-Induced Demyelination of the Rat Spinal Cord

Lazaros C. Triarhou, MD; Robert M. Herndon, MD

Arch Neurol. 1986;43(2):121-125.


Abstract

• Adult male Sprague-Dawley rats were injected intraspinally with 2 µL of 1% lysolecithin to induce demyelination. This was followed by systemic treatment with dexamethasone acetate for two weeks. Control groups were injected with lysolecithin but not treated. The animals were perfused at 8, 12, 28, and 60 days postoperatively, and the spinal cords were processed and examined histopathologically. The intraspinal injection of lysolecithin produced a focal area of primary demyelination followed by remyelination. In the steroid-treated groups, there was a suppression of the mononuclear phagocytic response, accompanied by slow clearance of the disrupted myelin sheaths and an apparent reduction in lesion size. Remyelination was substantially retarded in comparison with the controls. The findings suggest that steroids interfere with the process of remyelination, as they are known to do with myelination during development. Thus, dexamethasone appears to have a dual effect, decreasing demyelination but delaying remyelination.



Author Affiliations

From the Center for Brain Research (Drs Triarhou and Herndon) and the Department of Neurology (Dr Herndon), University of Rochester School of Medicine and Dentistry, New York. Dr Triarhou is now at Indiana University School of Medicine, Indianapolis.


Footnotes

Accepted for publication April 5, 1985.

Read in part before the 59th annual meeting of the American Association of Neuropathologists, St Louis, June 10, 1983.

Reprint requests to Division of Neuropathology, Department of Pathology, Indiana University School of Medicine, Medical Science Building, A 142, Indianapolis, IN 46223 (Dr Triarhou).



THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Interferon beta-1b and intravenous methylprednisolone promote lesion recovery in multiple sclerosis
Richert et al.
Mult Scler 2001;7:49-58.
ABSTRACT  

Brain Damage in Preterm Newborns: Might Enhancement of Developmentally Regulated Endogenous Protection Open a Door for Prevention?
Dammann and Leviton
Pediatrics 1999;104:541-550.
ABSTRACT | FULL TEXT  

Acceleration in the Rate of CNS Remyelination in Lysolecithin-Induced Demyelination
Pavelko et al.
J. Neurosci. 1998;18:2498-2505.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1986 American Medical Association. All Rights Reserved.